A recent rise in newly acquired hepatitis B infections across metropolitan Perth was likely driven by coincident introductions of multiple viral strains alongside limited local spread, according to an outbreak investigation published in BMC Infectious Diseases.
Hepatitis B virus is a blood-borne virus subject to national notification requirements in Australia. Even with the long-standing inclusion of the hepatitis B vaccine in the country’s childhood National Immunisation Program, both locally acquired infections and overseas acquisitions continue to occur. Public health authorities initiated the investigation following an observed increase in newly acquired hepatitis B presentations in the Perth metropolitan area between 1 August 2023 and 31 July 2024.
To assess the increase, investigators paired epidemiological reviews of patient demographics, disease onset dates, and potential exposures with laboratory investigations, applying whole genome sequencing for viral genotyping and phylogenetic analysis. The evaluation analyzed twenty newly acquired cases, while investigating an additional three cases. Among the cohorts examined, eighteen individuals, representing 78 percent of cases, were older than 30 years. Reported risk factors included casual unprotected sex in seventeen cases, representing 74 percent, overseas birth in eight cases, or 33 percent, and intravenous drug use in seven cases, or 30 percent.
The study also examined immunization records among the individuals, noting that four cases had documented receipt of at least three hepatitis B vaccine doses, although the timing between doses varied across these individuals. Genomic sequencing performed on twenty cases identified twelve locally acquired infections belonging to hepatitis B sub-genotype A2. In total, phylogenetic clustering resolved three separate sub-genotype A2 clusters as well as one sub-genotype B3 cluster across the sequenced samples.
The researchers noted that genomic surveillance faced specific technical challenges during the evaluation. Sequence diversity detected within individual patient specimens, termed within-host sequence heterogeneity, complicated relatedness determinations and restricted the definitive mapping of direct transmission chains. Nevertheless, whole genome sequencing provided valuable resolution that complemented standard epidemiological methods, which had uncovered few direct links between cases. The identified sub-genotype A2 increase was ultimately attributed to concurrent introductions of distinct strains into the metropolitan region combined with localized secondary transmission.
Subject of Research: Investigation of a rise in newly acquired hepatitis B in a metropolitan setting: insights from whole genome sequencing
Article Title: Investigation of a rise in newly acquired hepatitis B in a metropolitan setting: insights from whole genome sequencing
Article References: Stevenson, R., Ler, Y.-H., Levy, A., Speers, D., Glass, K., Scalley, B., & McEvoy, S. (2026). Investigation of a rise in newly acquired hepatitis B in a metropolitan setting: insights from whole genome sequencing. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14589-5
Image Credits: AI Generated
DOI: 10.1186/s12879-026-14589-5
Keywords: Investigation, rise, newly, acquired, hepatitis, metropolitan, setting, insights, whole, genome, sequencing
News Source: Kristina Jarvis. (November 13, 2026). Genome Sequencing Links Perth Hepatitis B Rise to Multiple Introductions. Scienmag.



